Search

everythinglearnresearchcommunity

for

Search:↓

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

5α-Reductase inhibitors can negatively impact sexual function.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Morphine increases testosterone breakdown in the rat brain and spinal cord.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Activating δ-opioid receptors can help hair grow.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

TSPO might help treat anxiety and depression.

A new compound may treat benign prostatic hyperplasia better than finasteride.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Aromoline and DRD4 are potential targets for osteoarthritis treatment.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

GnRH agonists can help manage recurrent priapism in sickle cell patients, but long-term safety is unclear.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Laminin-511 is involved in psoriasis development and can be regulated by cannabinoid receptor type 1.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Some herbs show promise as antiandrogenic agents.

Activating cannabinoid receptor 1 reduces certain keratin levels, potentially aiding psoriasis treatment.

Finasteride may help reduce impulsivity caused by pramipexole.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Different ligands change the shape of the TRPV3 ion channel in unique ways.

5α-reductase inhibitors may cause persistent sexual dysfunction and depression, needing more research on long-term effects.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.